Lobbying Activity Report

1576-23468

Organization: GlaxoSmithKline Inc.
Associated registration: 9293-1576-28
Lobbying Activity date: 2023-01-25
Arranged a meeting: Yes
Posted date: 2023-02-15

In-house lobbyists who participated in the lobbying activity: Laura Fitzgerald
Senior Public Office Holders who were lobbied in this activity: Isobel Mackenzie, Seniors Health Advocate
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
GSK will conduct activities related to advancement of GSK medicines and vaccines with stakeholders of the healthcare system.
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
COVID-19, Economic Development and Trade, Health, Hospitals, Industry
 
Senior officer who filed this Lobbying Activity Report: Sridhar Venkatesh
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Date Modified: